Navigation Links
GenWay Biotech extends the You Test You program overseas

(San Diego, CA) March 18, 2010 GenWay Biotech, Inc., ( the US-based diagnostic company that recently launched the You Test YouTM Cancer Assessment is expanding this cancer testing program internationally. An agreement has been executed to offer the You Test YouTM Cancer Assessment in Greece starting in April. Additional agreements are in progress for other European nations as well. GenWay currently offers this test in the United States and Canada.

Dr. Sergey Sikora, Vice President of Business Development, said, "The agreement with Greece is one of many on the horizon which will make the You Test You cancer testing service readily available to many countries worldwide that are interested in revolutionizing healthcare and facilitating self-testing for cancer."

The You Test YouTM Cancer Assessment is a unique program that enables consumers to directly access a cancer testing service without having to make an appointment with their own doctor. The You Test You platform is designed to empower consumers to be proactive about their health and their risk of having cancer. The test measures biomarkers associated with numerous types of cancer and aids in the early detection of cancer.

Early detection of cancer is the key to fighting cancer successfully. Extending this program to other countries could bring them to a higher level of healthcare with individuals being able to self-monitor themselves for diseases such as cancer.


Contact: Jill Dombrauckas, PhD
858-458-0866 x119
GenWay Biotech

Page: 1

Related biology news :

1. GenWay Biotechs You Test You puts early cancer detection tool in the hands of consumers
2. GenWay Clinical Laboratory receives accreditation from College of American Pathologists
3. General tumor marker test now offered by GenWay clinical laboratory
4. GenWay Biotech obtains exclusive rights to AMDLs DR-70 cancer test in US and Canada
5. New biotech advance to add heart healthy omega-3s to US diet
6. McGill, Quebec biotech firm partner for new bone-disease treatment
7. New edition of ASM Press biotechnology text announced
8. Biotech, nanotech and synthetic biology roles in future food supply explored
9. Tarantula venom-based MD therapy to be advanced by UB scientists biotech company
10. DoseCue(TM) Presents Positive Study Results at BioTech 2009
11. PDC Biotech GmbH Announces Close of Series A Financing
Post Your Comments:
(Date:10/27/2015)... October 27, 2015 Munich, ... Gaze Mapping technology (ASGM) automatically maps data from mobile ... Glasses , so that they can be quantitatively ... Munich, Germany , October 28-29, 2015. ... data from mobile eye tracking videos created with ...
(Date:10/26/2015)... LAS VEGAS , Oct. 26, 2015 ... an innovator in modern authentication and a founding member ... launch of its latest version of the Nok Nok™ ... to use standards-based authentication that supports existing and emerging ... Suite is ideal for organizations deploying customer-facing applications that ...
(Date:10/23/2015)... California , October 23, 2015 ... (SMI) announce a mobile plug and play integration of ... real-world tasks SensoMotoric Instruments (SMI) present ... wearable solutions for eye tracking and physiological data registration. ... SMI Eye Tracking Glasses 2w and physiological ...
Breaking Biology News(10 mins):
(Date:12/1/2015)... ... December 01, 2015 , ... Matthew “Tex” VerMilyea, PhD, HCLD, has joined Texas ... oversee all IVF lab procedures as well as continue his research efforts into the ... miles to Auckland, New Zealand to bring home a High Complexity Clinical Laboratory Director ...
(Date:11/30/2015)... ... ... announced the opening of a new core patient care hub with the opening of ... are part of GSCG’s expansion efforts in Latin America. , Both the Arica and ... from around the world. , The clinics will be headed by Victor Perez, M.D. and ...
(Date:11/30/2015)... HOLLISTON, Mass. , Nov. 30, 2015 /PRNewswire/ ... HART ), a biotechnology company developing bioengineered ... has received written notification from The NASDAQ Stock ... minimum bid price requirements. The letter noted that ... of HART,s common stock having exceeded $1.00 per ...
(Date:11/30/2015)... Human Longevity, Inc. (HLI), the genomics-based, technology-driven ... Genomics, Inc., a leading genome informatics company offering highly ... The San Diego -based company has ... and Co-founder, Ashley Van Zeeland , Ph.D., who is ... of the deal were not disclosed. ...
Breaking Biology Technology: